Company Filing History:
2 out of 2,009 
2 out of 276 
1 out of 15,475 
Years Active: 2011-2017
Title: Innovations by Denise Kothe
Introduction
Denise Kothe is a prominent inventor based in Birmingham, AL (US). She has made significant contributions to the field of immunology, particularly in the development of innovative approaches to combat human immunodeficiency virus type 1 (HIV-1). With a total of 2 patents, her work focuses on enhancing immune responses against HIV.
Latest Patents
Denise Kothe's latest patents include groundbreaking inventions aimed at improving HIV treatment. The first patent is titled "Modified human immunodeficiency virus type 1 (HIV-1) group M consensus envelope glycoproteins capable of inducing broadly reactive T- and B-cell responses." This invention relates to HIV-1 envelope polypeptides that comprise the consensus envelope of SEQ ID NO: 35, along with compositions and methods for their use. The second patent is "Nucleic acids encoding modified human immunodeficiency virus type 1 (HIV-1) group M consensus envelope glycoproteins." This invention focuses on an immunogen designed to induce antibodies that neutralize a wide spectrum of HIV primary isolates and stimulate T cell immune responses.
Career Highlights
Denise Kothe has had a distinguished career, working at esteemed institutions such as Duke University and the University of Alabama. Her research has significantly advanced the understanding of HIV and the development of potential vaccines.
Collaborations
Throughout her career, Denise has collaborated with notable colleagues, including Barton F. Haynes and Feng Gao. These partnerships have contributed to her innovative research and the successful development of her patents.
Conclusion
Denise Kothe's contributions to the field of immunology through her patents and research have the potential to make a lasting impact on HIV treatment and prevention. Her work exemplifies the importance of innovation in addressing global health challenges.